Herpesviridae, a family of DNA viruses, personify the pattern of viral co-divergence with their vertebrate hosts, dating back hundreds of millions of years. More specifically, across the three subfamilies (Alpha-, Beta-, Gamma-herpesvirinae), there have been multitudes of within-host viral lineage duplications in which viral descendants followed the phylogenetic history of their host species. When chimpanzees and humans diverged from their common ancestor, 6 million years ago, Human Herpes Simplex virus Type 1 (HSV-1) and Chimpanzee Herpes Simplex virus (ChHV) also diverged from their common Herpes Simplex virus ancestor of the Alphaherpesvirinae subfamily. Conversely, a zoonotic ChHV infection to human forerunners occurred 1.5 million years ago, gave birth to Human Herpes Simplex virus Type 2 (HSV-2). Such temporally distinct but longer association of HSV-1 with human host explains the differences between HSV-1 and HSV-2 infections, and why HSV-2 is genetically closer to ChHV than to HSV-1 (Sehrawat, Kumar, & Rouse, 2018; Wertheim, Smith, Smith, Scheffler, & Kosakovsky Pond, 2014).HSV-1 is, therefore, a highly successful pathogen. Nearly all human beings, by the time they reach adolescence, are infected with multiple herpesviruses, HSV-1 being the principal, this family of viruses accounts for 35-40 billion human infections worldwide, making herpesviruses among the most prevalent pathogens known to exist. This long co-evolution gave HSV-1 the ability to evade host immunity using a number of strategies. These include infection of tissues with limited accessibility to immune mediators, establishment of latency which allows minimal immune recognition and numerous active immunomodulatory procedures. Immune evasion is responsible for lifelong infection. In addition, immunomodulatory activity makes the HSV-1 infected hosts either more resistant or susceptible to other disease situations, such as other infections, allergies and tumors. For example, in immunologic models of cancer progression, herpesviruses display many mechanisms of interaction with the nascent cancer cells, including enhanced immunosurveillance, tumor elimination, or maintenance of precancerous equilibrium triggered by latency-driven immune modulation. In contrast, the immunomodulatory environment triggered by herpesvirus latency promotes more rapid tumor immune evasion and enhances the development or recruitment of immunosuppressive cells into the tumor microenvironment (Sehrawat et al., 2018;Wertheim et al., 2014).